Abstract

Real-world experience of adalimumab in the treatment of hidradenitis suppurativa

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Anti-Saccharomyces cerevisiae IgG and IgA antibodies are associated with systemic inflammation and advanced disease in hidradenitis suppurativa
Hervé Bachelez ... Florence Assan
The Journal of Allergy and Clinical Immunology | VOL. 146
Hervé Bachelez, et. al.Hervé Bachelez ... Florence Assan
13 Feb 2020
Metabolic endoscopy and a simplified low-carbohydrate–high-dietary fiber template as novel treatments for hidradenitis suppurativa – A case series
Esther Idowu ... Jude A Oben
JAAD Case Reports | VOL. 34
Esther Idowu, et. al.Esther Idowu ... Jude A Oben
19 Feb 2023
No Evident Systemic Terminal Complement Pathway Activation in Hidradenitis Suppurativa
Hessel H Van Der Zee ... Jeffrey Damman
Journal of Investigative Dermatology | VOL. 141
Hessel H Van Der Zee, et. al.Hessel H Van Der Zee ... Jeffrey Damman
09 Jul 2021
Skin Microbiota Perturbations Are Distinct and Disease Severity–Dependent in Hidradenitis Suppurativa
Maia Paul ... Heidi H Kong
Journal of Investigative Dermatology | VOL. 140
Maia Paul, et. al.Maia Paul ... Heidi H Kong
17 Sep 2019
View more papers

More From: Journal of the American Academy of Dermatology

Paper Title
Journal
Date
Author
Answers to CME examination
-
Journal of the American Academy of Dermatology | VOL. 90
--
01 Jun 2024
Table of contents
-
Journal of the American Academy of Dermatology | VOL. 90
--
01 Jun 2024
Answers to CME examination
-
Journal of the American Academy of Dermatology | VOL. 90
--
01 Jun 2024
Information for readers
-
Journal of the American Academy of Dermatology | VOL. 90
--
01 Jun 2024
View more papers